- Home
- CNC vs NUWE Comparison
CNC vs NUWE Comparison
Compare CNC & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNC | NUWE |
|---|---|---|
| Founded | 1984 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.5B | 2.9M |
| IPO Year | 2001 | N/A |
Fundamental Metrics
Financial Performance| Metric | CNC | NUWE |
|---|---|---|
| Price | $39.36 | $2.50 |
| Analyst Decision | Hold | |
| Analyst Count | 17 | 0 |
| Target Price | ★ $40.06 | N/A |
| AVG Volume (30 Days) | ★ 9.3M | 70.2K |
| Earning Date | 10-29-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $167,680,000,000.00 | $8,167,999.00 |
| Revenue This Year | $31.16 | $6.53 |
| Revenue Next Year | $0.94 | $51.63 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.57 | N/A |
| 52 Week Low | $25.08 | $2.02 |
| 52 Week High | $66.81 | $70.14 |
Technical Indicators
Market Signals| Indicator | CNC | NUWE |
|---|---|---|
| Relative Strength Index (RSI) | 61.63 | 43.58 |
| Support Level | $34.39 | $2.02 |
| Resistance Level | $39.93 | $2.58 |
| Average True Range (ATR) | 1.57 | 0.21 |
| MACD | 0.34 | 0.03 |
| Stochastic Oscillator | 90.90 | 47.47 |
Price Performance
Historical ComparisonAbout CNC Centene Corporation
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.